Scientists test 'Cancer-Killing Virus' in patients
NCT ID NCT06311578
Summary
This early-stage study is testing a new treatment called JNJ-87704916, which is a modified virus designed to infect and kill cancer cells. It will be injected directly into tumors of patients with advanced solid tumors who have run out of standard treatment options. The main goals are to find a safe dose and see if the virus, given alone or with an immunotherapy drug, can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier de l'Universite de Montreal
RECRUITINGMontreal, Quebec, H2X 0A9, Canada
-
Fox Chase Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19111, United States
-
Gustave Roussy
RECRUITINGVillejuif, 94805, France
-
Hosp Univ Fund Jimenez Diaz
RECRUITINGMadrid, 28040, Spain
-
Hosp Univ Hm Sanchinarro
RECRUITINGMadrid, 28050, Spain
-
Hosp Univ Vall D Hebron
RECRUITINGBarcelona, 08035, Spain
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
-
Toronto General Hospital
RECRUITINGToronto, Ontario, M5G 2C4, Canada
-
UPMC Cancer Centers
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
Conditions
Explore the condition pages connected to this study.